Cargando…
Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas
BACKGROUND: The prognosis of patients with progressive or recurrent high-grade gliomas (HGGs) after surgery remains poor. Iodine-125 brachytherapy is emerging as a salvage method for the treatment of gliomas. This study aimed to investigate whether permanent iodine-125 brachytherapy could be used as...
Autores principales: | Wang, Congxiao, Liu, Shifeng, Peng, Lijing, Zhang, Kaixian, Li, Wei, Zhang, Hao, Luan, Ying, Li, Peishun, Hu, Xiaokun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315528/ https://www.ncbi.nlm.nih.gov/pubmed/32580723 http://dx.doi.org/10.1186/s12885-020-07086-8 |
Ejemplares similares
-
Correction to: Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas
por: Wang, Congxiao, et al.
Publicado: (2020) -
Effect of neoadjuvant iodine-125 brachytherapy upon resection of glioma
por: Wang, Congxiao, et al.
Publicado: (2022) -
Value of CT-MRI fusion in iodine-125 brachytherapy for high-grade glioma
por: Gao, Yang, et al.
Publicado: (2017) -
Iodine-125 brachytherapy treatment for newly diagnosed brain metastasis in non-small cell lung cancer: A biocentric analysis
por: Yang, Lili, et al.
Publicado: (2022) -
Dosimetry verification of 3D-printed individual template based on CT-MRI fusion for radioactive (125)I seed implantation in recurrent high-grade gliomas
por: Liu, Shifeng, et al.
Publicado: (2019)